Microlithiasis Alveolar

Alveolar microlithiasis (Microlithiasis alveolaris) is a rare lung disease characterized by the formation of small stones (microliths) in the alveoli of the lungs. This process leads to a decrease in the volume of lung tissue and a deterioration in respiratory function.

The disease is most often diagnosed in men between 30 and 50 years of age, although it can affect anyone at any age. The causes of alveolar microlithiasis are still unknown, but some studies indicate a genetic predisposition to this disease.

The main symptom of alveolar microlithiasis is cough, which may be accompanied by intensification or weakening depending on the stage of the disease. However, in some cases, the disease may be asymptomatic, which makes its diagnosis difficult.

Various examination methods are used to diagnose alveolar microlithiasis, including radiography, high-resolution computed tomography (HCT), and bronchoscopy. For diagnostic accuracy, a biopsy of lung tissue may be required.

Treatment of alveolar microlithiasis is reduced to symptomatic therapy, which is aimed at improving respiratory function and reducing cough. In some cases, surgery may be required.

In general, alveolar microlithiasis is a rare disease, but its diagnosis and treatment require specialized medical intervention. If you suspect you have this disease, consult your doctor for diagnosis and to determine the most effective treatment.